347 related articles for article (PubMed ID: 11239793)
21. [Inhibitors of HMG CoA reductase: new modes of action, new indications?].
Essig M; Vrtovsnik F; Friedlander G
Therapie; 2000; 55(1):43-9. PubMed ID: 10860000
[TBL] [Abstract][Full Text] [Related]
22. Pleiotropic effects of statins. - Basic research and clinical perspectives -.
Zhou Q; Liao JK
Circ J; 2010 May; 74(5):818-26. PubMed ID: 20424337
[TBL] [Abstract][Full Text] [Related]
23. Pleiotropic effects of HMG-CoA reductase inhibitors.
Bocan TM
Curr Opin Investig Drugs; 2002 Sep; 3(9):1312-7. PubMed ID: 12498006
[TBL] [Abstract][Full Text] [Related]
24. Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress.
Mason RP; Walter MF; Jacob RF
Circulation; 2004 Jun; 109(21 Suppl 1):II34-41. PubMed ID: 15173061
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin converting enzyme (ACE) and HydroxyMethylGlutaryl-CoA (HMG-CoA) reductase inhibitors in the forefront of pharmacology of endothelium.
Chłopicki S; Gryglewski RJ
Pharmacol Rep; 2005; 57 Suppl():86-96. PubMed ID: 16415489
[TBL] [Abstract][Full Text] [Related]
26. Pluripotential mechanisms of cardioprotection with HMG-CoA reductase inhibitor therapy.
Rosenson RS
Am J Cardiovasc Drugs; 2001; 1(6):411-20. PubMed ID: 14728000
[TBL] [Abstract][Full Text] [Related]
27. Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?
Comparato C; Altana C; Bellosta S; Baetta R; Paoletti R; Corsini A
Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):328-43. PubMed ID: 11887430
[TBL] [Abstract][Full Text] [Related]
28. HMG-CoA reductase inhibitors inhibit endothelial exocytosis and decrease myocardial infarct size.
Yamakuchi M; Greer JJ; Cameron SJ; Matsushita K; Morrell CN; Talbot-Fox K; Baldwin WM; Lefer DJ; Lowenstein CJ
Circ Res; 2005 Jun; 96(11):1185-92. PubMed ID: 15905463
[TBL] [Abstract][Full Text] [Related]
29. Pleiotropic effects of statin therapy: molecular mechanisms and clinical results.
Wang CY; Liu PY; Liao JK
Trends Mol Med; 2008 Jan; 14(1):37-44. PubMed ID: 18068482
[TBL] [Abstract][Full Text] [Related]
30. Direct vascular and cardioprotective effects of rosuvastatin, a new HMG-CoA reductase inhibitor.
Jones SP; Gibson MF; Rimmer DM; Gibson TM; Sharp BR; Lefer DJ
J Am Coll Cardiol; 2002 Sep; 40(6):1172-8. PubMed ID: 12354446
[TBL] [Abstract][Full Text] [Related]
31. Recent developments in the effects of nitric oxide-donating statins on cardiovascular disease through regulation of tetrahydrobiopterin and nitric oxide.
Ma S; Ma CC
Vascul Pharmacol; 2014 Nov; 63(2):63-70. PubMed ID: 25139660
[TBL] [Abstract][Full Text] [Related]
32. Direct effects of statins on cells primarily involved in atherosclerosis.
Chen H; Ikeda U; Shimpo M; Shimada K
Hypertens Res; 2000 Mar; 23(2):187-92. PubMed ID: 10770267
[TBL] [Abstract][Full Text] [Related]
33. Pleiotropic effects of statins on the vascular tissue.
Ikeda U; Shimada K
Curr Drug Targets Cardiovasc Haematol Disord; 2001 Jun; 1(1):51-8. PubMed ID: 12769664
[TBL] [Abstract][Full Text] [Related]
34. Direct vascular effects of HMG-CoA reductase inhibitors.
Bellosta S; Bernini F; Ferri N; Quarato P; Canavesi M; Arnaboldi L; Fumagalli R; Paoletti R; Corsini A
Atherosclerosis; 1998 Apr; 137 Suppl():S101-9. PubMed ID: 9694549
[TBL] [Abstract][Full Text] [Related]
35. How do HMG-CoA reductase inhibitors prevent stroke?
Bedi A; Flaker GC
Am J Cardiovasc Drugs; 2002; 2(1):7-14. PubMed ID: 14727994
[TBL] [Abstract][Full Text] [Related]
36. [Novel actions of HMG-CoA reductase inhibitors(statins)--vascular and cerebral protection through inhibition of small GTPase Rho].
Sawada N; Itoh H; Nakao K
Nihon Rinsho; 2001 Dec; 59(12):2470-5. PubMed ID: 11766357
[TBL] [Abstract][Full Text] [Related]
37. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation.
Wagner AH; Köhler T; Rückschloss U; Just I; Hecker M
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):61-9. PubMed ID: 10634801
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective properties of statins in cerebral ischemia and stroke.
Vaughan CJ; Delanty N
Stroke; 1999 Sep; 30(9):1969-73. PubMed ID: 10471452
[TBL] [Abstract][Full Text] [Related]
39. Endothelium-dependent effects of statins.
Wolfrum S; Jensen KS; Liao JK
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):729-36. PubMed ID: 12615672
[TBL] [Abstract][Full Text] [Related]
40. Statins and ischaemia reperfusion injury: a molecular biological review.
Abdul Rahman MN; Chetter IC
Curr Vasc Pharmacol; 2010 Nov; 8(6):831-5. PubMed ID: 19485917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
